Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 643692, 8 pages
http://dx.doi.org/10.1155/2009/643692
Methodology Report

Methyl-CpG-Binding PCR of Bloodspots for Confirmation of Fragile X Syndrome in Males

1Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan
2Department of Pediatrics, Chi Mei Medical Center, Tainan, Taiwan
3The Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Kaohsiung, Taiwan
4Department of Pediatrics, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan

Received 28 February 2009; Revised 30 June 2009; Accepted 10 August 2009

Academic Editor: Wolfgang Schulz

Copyright © 2009 Ching-Cherng Tzeng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Hagerman, “The molecular biology of the fragile X mutation,” in Fragile X Syndrome: Diagnosis, Treatment and Research, R. J. Hagerman and A. Cronister, Eds., pp. 88–113, Johns Hopkins University Press, Baltimore, Md, USA, 1996. View at Google Scholar
  2. S. L. Nolin, W. T. Brown, A. Glicksman et al., “Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles,” The American Journal of Human Genetics, vol. 72, no. 2, pp. 454–464, 2003. View at Publisher · View at Google Scholar
  3. P. J. Hagerman and R. J. Hagerman, “The fragile-X premutation: a maturing perspective,” American Journal of Human Genetics, vol. 74, no. 5, pp. 805–816, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. G. T. Baranek, J. E. Roberts, F. J. David et al., “Developmental trajectories and correlates of sensory processing in young boys with fragile X syndrome,” Physical and Occupational Therapy in Pediatrics, vol. 28, no. 1, pp. 79–98, 2008. View at Publisher · View at Google Scholar
  5. M. G. Torrioli, S. Vernacotola, L. Peruzzi et al., “A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys,” American Journal of Medical Genetics A, vol. 146, no. 7, pp. 803–812, 2008. View at Publisher · View at Google Scholar
  6. R. J. Hagerman, E. Berry-Kravis, W. E. Kaufmann et al., “Advances in the treatment of fragile X syndrome,” Pediatrics, vol. 123, no. 1, pp. 378–390, 2009. View at Publisher · View at Google Scholar
  7. R. A. Saul, M. Friez, K. Eaves et al., “Fragile X syndrome detection in newborns: pilot study,” Genetics in Medicine, vol. 10, no. 10, pp. 714–719, 2008. View at Publisher · View at Google Scholar
  8. L. A. Larsen, K. Grønskov, B. Nørgaard-Pedersen, K. Brøndum-Nielsen, L. Hasholt, and J. Vuust, “High-throughput analysis of fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis,” Human Genetics, vol. 100, no. 5–6, pp. 564–568, 1997. View at Google Scholar
  9. C.-C. Tzeng, S.-J. Lin, Y.-J. Chen et al., “An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome,” Diagnostic Molecular Pathology, vol. 10, no. 1, pp. 34–40, 2001. View at Publisher · View at Google Scholar
  10. J. G. Herman, J. R. Graff, S. Myöhänen et al., “Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 18, pp. 9821–9826, 1996. View at Publisher · View at Google Scholar
  11. S. Das, T. Kubota, M. Song et al., “Methylation analysis of the fragile X syndrome by PCR,” Genetic Testing, vol. 1, no. 3, pp. 151–155, 1998. View at Google Scholar
  12. I. Panagopoulos, C. Lassen, U. Kristoffersson, and P. Aman, “A methylation PCR approach for detection of fragile X syndrome,” Human Mutation, vol. 14, no. 1, pp. 71–79, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Weinhäusel and O. A. Haas, “Evaluation of the fragile X (FRAXA) syndrome with methylation-sensitive PCR,” Human Genetics, vol. 108, no. 6, pp. 450–458, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Zhou, J. M. S. Lum, G.-H. Yeo, J. Kiing, S. K. H. Tay, and S. S. Chong, “Simplified molecular diagnosis of fragile X syndrome by fluorescent methylation-specific PCR and GeneScan analysis,” Clinical Chemistry, vol. 52, no. 8, pp. 1492–1500, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Raizis, F. Schmitt, and J.-P. Jost, “A bisulfite method of 5-methylcytosine mapping that minimizes template degradation,” Analytical Biochemistry, vol. 226, no. 1, pp. 161–166, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Munson, J. Clark, K. Lamparska-Kupsik, and S. S. Smith, “Recovery of bisulfite-converted genomic sequences in the methylation-sensitive QPCR,” Nucleic Acids Research, vol. 35, no. 9, pp. 2893–2903, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Rauch and G. P. Pfeifer, “Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer,” Laboratory Investigation, vol. 85, no. 9, pp. 1172–1180, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Gebhard, L. Schwarzfischer, T. H. Pham, R. Andreesen, A. Mackensen, and M. Rehli, “Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR,” Nucleic Acids Research, vol. 34, no. 11, article e82, 2006. View at Google Scholar · View at Scopus
  19. S. Yegnasubramanian, X. Lin, M. C. Haffner, A. M. DeMarzo, and W. G. Nelson, “Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation,” Nucleic Acids Research, vol. 34, no. 3, article e19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Renbaum, D. Abrahamove, A. Fainsod, G. G. Wilson, S. Rottem, and A. Razin, “Cloning, characterization, and expression in Escherichia coli of the gene coding for the CpG DNA methylase from Spiroplasma sp. strain MQ1 (M·SssI),” Nucleic Acids Research, vol. 18, no. 5, pp. 1145–1152, 1990. View at Google Scholar
  21. N. Umetani, M. F. de Maat, T. Mori, H. Takeuchi, and D. S. Hoon, “Synthesis of universal unmethylated control DNA by nested whole genome amplification with phi29 DNA polymerase,” Biochemical and Biophysical Research Communications, vol. 329, no. 1, pp. 219–223, 2005. View at Google Scholar
  22. C.-C. Tzeng, P.-Y. Tzeng, H. S. Sun, R. M. Chen, and S.-J. Lin, “Implication of screening for FMR1 and FMR2 gene mutation in individuals with nonspecific mental retardation in Taiwan,” Diagnostic Molecular Pathology, vol. 9, no. 2, pp. 75–80, 2000. View at Publisher · View at Google Scholar
  23. I. K. Hornstra, D. L. Nelson, S. T. Warren, and T. P. Yang, “High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome,” Human Molecular Genetics, vol. 2, no. 10, pp. 1659–1665, 1993. View at Google Scholar · View at Scopus
  24. B. Genç, H. Müller-Hartmann, and M. Zeschnigk, “Methylation mosaicism of 5-(CGG)(n)-3 repeats in fragile X, premutation and normal individuals,” Nucleic Acids Research, vol. 28, no. 10, pp. 2141–2152, 2000. View at Google Scholar
  25. B. Hendrich and A. Bird, “Identification and characterization of a family of mammalian methyl-CpG binding proteins,” Molecular and Cellular Biology, vol. 18, no. 11, pp. 6538–6547, 1998. View at Google Scholar
  26. M. F. Fraga, E. Ballestar, G. Montoya, P. Taysavang, P. A. Wade, and M. Esteller, “The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties,” Nucleic Acids Research, vol. 31, no. 6, pp. 1765–1774, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. S. H. Cross, J. A. Charlton, X. Nan, and A. P. Bird, “Purification of CpG islands using a methylated DNA binding column,” Nature Genetics, vol. 6, no. 3, pp. 236–244, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. R. J. Klose, S. A. Sarraf, L. Schmiedeberg, S. M. McDermott, I. Stancheva, and A. P. Bird, “DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG,” Molecular Cell, vol. 19, no. 5, pp. 667–678, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. C.-L. Jiang, S.-G. Jin, and G. P. Pfeifer, “MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex,” The Journal of Biological Chemistry, vol. 279, no. 50, pp. 52456–52464, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. S. L. Nolin, A. Glicksman, G. E. Houck Jr., W. T. Brown, and C. S. Dobkin, “Mosaicism in fragile X affected males,” American Journal of Medical Genetics, vol. 51, no. 4, pp. 509–512, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Rousseau, D. Heitz, J. Tarleton et al., “A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases,” American Journal of Human Genetics, vol. 55, no. 2, pp. 225–237, 1994. View at Google Scholar
  32. S. Hecimovic, I. Barišic, A. Müller et al., “Expand long PCR for fragile X mutation detection,” Clinical Genetics, vol. 52, no. 3, pp. 147–154, 1997. View at Google Scholar
  33. A. Saluto, A. Brussino, F. Tassone et al., “An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene,” The Journal of Molecular Diagnostics, vol. 7, no. 5, pp. 605–612, 2005. View at Google Scholar
  34. C. M. Strom, D. Huang, Y. Li et al., “Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for fragile X syndrome,” Genetics in Medicine, vol. 9, no. 4, pp. 199–207, 2007. View at Publisher · View at Google Scholar
  35. F. Tassone, R. Pan, K. Amiri, A. K. Taylor, and P. J. Hagerman, “A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations,” The Journal of Molecular Diagnostics, vol. 10, no. 1, pp. 43–49, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. E. D. Dodds, F. Tassone, P. J. Hagerman, and C. B. Lebrilla, “Polymerase chain reaction, nuclease digestion, and mass spectrometry based assay for the trinucleotide repeat status of the fragile X mental retardation 1 gene,” Analytical Chemistry, vol. 81, no. 13, pp. 5533–5540, 2009. View at Publisher · View at Google Scholar